Join us for a webinar focused on anti-racist commissioning where we will be shaping a practical, system-wide approach to tackling structural racism through commissioning in public health.

Webinar Details

Date: 29th April 2026
Time: 1:00pm – 2:30pm

About the session

London is one of the most diverse cities in the world, yet stark and preventable health inequalities persist. Structural racism is embedded across systems including commissioning and continues to influence access, experience, and outcomes in public services.

While racism is increasingly recognised as a public health issue, commissioning practice has not yet consistently developed the tools, confidence, or approaches needed to address it effectively. 

This webinar will form a critical starting point for demonstrating the value of integrating racial equity into commissioning, supporting a more effective, preventative, and equitable system. The webinar will inform the development of an anti-racist commissioning toolkit as we aim to move beyond commitment and into practical action through Anti-Racist Commissioning (ARC).

This webinar is part of the London Association of Directors of Public Health (ADPH London) Tackling Racism and Inequality programme, delivered in collaboration with consultant, Jessica Lubin.

Click here to register on eventbrite

Published in the Journal of Public Health at the start of 2026, Racism and Racial Health Inequity: Four Theories for Public Health identifies four social theories to combat racism and advance racial health equity. These theories emerged through the Trust and Cohesion workstream’s engagement with two anthropologists, Dr Caroline Parker and Professor Melissa Parker.

The publication outlines a set of conceptual tools designed to help public health professionals dismantle racism and reduce disparities by moving beyond treating “race” as a static variable, and instead addressing the social structures that produce health inequities.

You can access the full paper here

The NHS is committed to reducing healthcare inequalities and delivering equitable access, excellent experiences and optimal outcomes for everybody. To achieve this, they need to understand and respond to the needs of all the communities they serve. High quality data that helps them understand who is experiencing health inequalities is critical to this.

This plan sets out targeted actions to strengthen the quality, consistency and completeness of ethnicity data recording. It supports NHS organisations to identify and act on issues that affect their ability to record and analyse ethnic health inequalities data.

Access the full plan here

There was much controversy at the start of the year over the rumoured closure of  Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London. A  petition was formed to urge the Royal London Hospital and governing health authorities to maintain and adequately fund the Sickle Cell Day Unit, securing its services for future generations.

https://www.change.org/p/prevent-closure-of-the-sickle-cell-day-unit 

The organisers argue that the closing of this facility would have a devastating impact on the hundreds of families who rely on its specialised services.  Following sustained campaigning by youth worker Delo Biyelo, with later support from organisations like ACLT charity, the campaign was even covered by ITV News 

But the Royal London Hospital sees the situation differently.   Barts Health NHS Trust put out this statement

“We recognise the strength of feeling and support that our same day emergency care (SDEC) pilot has received, which is a testament to the hard work of our teams.Funded by the North East London integrated care board, it involved testing an alternative route for treating emergency patients with sickle cell disease who were experiencing acute pain. This was alongside the normal route of being treated through our A&E. We did this so we could evaluate its impact and plan more robustly for future services. The pilot ran from September 2025 to the end of January.  There is no change to the way we manage patients with sickle cell disease, and our Haematology Day Unit remains open for all our elective transfusion therapies.  Patients with sickle cell disease will continue to receive specialist-led care at our hospital.  
We are committed to improving pathways for the management of pain in patients with sickle cell disease, both acute and chronic, and will continue to welcome input into service design. Our team are in the process of collecting data and feedback on how the pathway was used, to share with the ICB and help inform future funding plans.”